← Open Payments lookup

ZAINEB SHAMS: Open Payments

NPI 1487905709 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$21,939 in 179 payments from 34 companies in 2025. Trend: 2023 $15,348 · 2024 $17,498 · 2025 $21,939

Speaker / faculty: $16,500Food & beverage: $4,269Travel & lodging: $689Consulting: $480
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP35$16,995
Daiichi Sankyo Inc.24$1,539
PFIZER INC.12$796
Janssen Biotech, Inc.20$451
Gilead Sciences, Inc.8$274
Novartis Pharmaceuticals Corporation12$190
E.R. Squibb & Sons, L.L.C.11$155
EMD Serono, Inc.2$144
Takeda Pharmaceuticals U.S.A., Inc.5$143
Merck Sharp & Dohme LLC6$128

Products named: DATROWAY, IMFINZI, XTANDI, Enhertu, TAGRISSO, RYBREVANT, Trodelvy, OPDIVO.

Industry payments across TX — which companies pay providers there.